Kenneth Galbraith Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 22 hours ago
Kenneth Galbraith has an estimated net worth of at least $10.3 million*, as of March 11, 2026. They own 226,842 shares of ZYME stock. They have sold 213,490 shares of ZYME stock since 2021, for an estimated $4.5 million.
Kenneth Galbraith $ZYME SEC Form 4 Insider Trading
Kenneth Galbraith has filed a total of 8 insider trades in $ZYME since 2021. Their most recent trade was a sale of 30,424 shares, made on Jan 12, 2026. Their largest trade was a sale of 47,528 shares, made on Dec 22, 2025. We estimate that they now own 226,842 shares of $ZYME, worth an estimated $5.9 million.
Insider Trading at $ZYME
There have been a total of 74 insider trades reported at $ZYME since 2021, with 9.1 million shares purchased and 387,570 shares sold. The most active insider traders in $ZYME stock have been Kenneth Galbraith, Paul Andrew Moore, and Christopher Astle. The most recent trade was a sale of 6,120 shares reported by Mark Hollywood (EVP & Chief Operating Officer), made on Jan 12, 2026.
History of Insider Stock Trades by Kenneth Galbraith
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ZYME
|
Sale | 30,424 | Jan 12, 2026 | Jan. 12, 2026, 8:07 p.m. |
|
ZYME
|
Sale | 31,686 | Jan 05, 2026 | Jan. 5, 2026, 9:20 p.m. |
|
ZYME
|
Sale | 22,657 | Jan 05, 2026 | Jan. 5, 2026, 9:20 p.m. |
|
ZYME
|
Sale | 47,528 | Dec 22, 2025 | Dec. 22, 2025, 6:52 p.m. |
|
ZYME
|
Sale | 23,885 | Jan 06, 2025 | Jan. 6, 2025, 9:34 p.m. |
|
ZYME
|
Sale | 33,406 | Jan 06, 2025 | Jan. 6, 2025, 9:34 p.m. |
|
ZYME
|
Sale | 18,198 | Jan 05, 2024 | Jan. 8, 2024, 7:23 p.m. |
|
ZYME
|
Sale | 5,706 | Jan 08, 2024 | Jan. 8, 2024, 7:23 p.m. |
$ZYME Executives and Stock Owners with Insider Trades
-
Kenneth Galbraith, Chair & CEO
-
Paul Andrew Moore, Chief Scientific Officer
-
Christopher Astle, SVP & Chief Financial Officer
-
Neil Josephson, Chief Medical Officer
-
Ali Tehrani, Chief Executive Officer
-
Jeffrey T L Smith, EVP & Chief Medical Officer
-
Mark Hollywood, EVP & Chief Operating Officer
-
Neil A Klompas, Chief Operating Officer
-
Neil A Klompas, President & COO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.